Clik here to view.
Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated...
TOKYO & BASKING RIDGE, N.J. The first patients have been dosed in three global, randomized phase 3 trials evaluating the efficacy and safety of datopotamab deruxtecan (Dato-DXd)-based...
View ArticleClik here to view.
bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung
SAN ANTONIO bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage lung cancer and other lung...
View ArticleClik here to view.
US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar...
SHANGHAI, China & JERSEY CITY, N.J. Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the US Food and Drug Administration (FDA) has accepted the Biologic License...
View ArticleClik here to view.
PopVax Announces 1.15 Million USD in Funding from the Bill ＆ Melinda Gates...
MUMBAI, India & HYDERABAD, India PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using computational protein design, is pleased to announce...
View ArticleClik here to view.
SCIEX to Localize the 6500+ systems in China, starting this December 2024
FRAMINGHAM, Mass. SCIEX, a global leader in life science analytical technologies, announces the localization of the SCIEX Triple Quad 6500+ system and the QTRAP 6500+ system in China. This...
View ArticleClik here to view.
Parse推出GigaLab，将单细胞测序能力扩大到每年数十亿个细胞
西雅图 (美国商业资讯)– 易于获取的可扩展单细胞测序解决方案的领先提供商Parse Biosciences今天宣布推出Parse GigaLab™，将单细胞测序能力扩展到每年数十亿个细胞。GigaLab利用Parse的Evercode™单细胞技术，通过扩大工作流程和提高自动化程度，实现了被认为在现有单细胞方法下无法获取的发现。...
View ArticleClik here to view.
パース・バイオサイセンシズ、GigaLabを立ち上げ、シングルセル シーケンシングを年間数十億個に拡大
シアトル （ビジネスワイヤ） — アクセスしやすくスケーラブルなシングルセル シーケンシング ソリューションの大手プロバイダーであるパース・バイオサイエンシズは、シングルセル シーケンシングを年間数十億個の細胞に拡張するParse GigaLab™の立ち上げを発表しました。GigaLabは、スケールアップされたワークフローと拡張自動化機能を備えたパースのEvercode™シングルセル...
View ArticleClik here to view.
Clik here to view.
Organon完成对Dermavant的收购，包括其创新皮肤疗法VTAMA®（苯烯莫德）1%乳膏
新泽西州泽西市 (美国商业资讯)– 以改善女性终生健康为使命的全球医疗保健公司Organon (NYSE: OGN) 今天宣布成功完成对Roivant (NASDAQ: ROIV) 旗下Dermavant Sciences Ltd.的收购。Dermavant是一家专注于开发和商业化免疫皮肤病创新治疗解决方案的公司。如需了解交易条款概要，请参阅我们之前发布的公告。...
View ArticleClik here to view.
Medidata and Cogstate Strike Strategic Partnership Transforming Clinical...
NEW YORK Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, today announced a partnership with neuroscience solutions leader...
View ArticleClik here to view.
Zai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating...
SHANGHAI & CAMBRIDGE, Mass. Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced positive topline results from the company’s Phase 3 multi-center trial evaluating the safety and efficacy...
View ArticleClik here to view.
ATLATL Hong Kong Innovation Center Officially Opens, Providing One-Stop...
HONG KONG ATLATL Hong Kong Innovation Center (ATLATL Hong Kong), a new state-of-the-art research facility designed to provide immediate, move-in-ready laboratory space for life science and biotech...
View ArticleClik here to view.
ベイジーン、大切な取締役ドナルド・グレイザー氏の死を悼む
カリフォルニア州、サンマテオ （ビジネスワイヤ） — がん領域におけるグローバル企業であるベイジーン（NASDAQ：BGNE、HKEX：06160、SSE：688235）は、ドナルド・グレイザー氏が先ごろ逝去されたことをお知らせします。同氏は取締役会のメンバーであり、指名・コーポレートガバナンス委員会の委員長を務めました。...
View ArticleClik here to view.
Boomi、ライフサイエンス業界全体のデジタル・トランスフォーメーションを加速すべくBASE life scienceと提携
ペンシルベニア州コンショホッケン （ビジネスワイヤ） — インテリジェントな統合と自動化のリーダーであるBoomiは、インフォシスの子会社であり、ライフサイエンス業界向けのクラウドベースシステムの最適化に特化したマネージド・サービス・プロバイダーであるBASE life science（BASE）との提携を発表しました。...
View ArticleClik here to view.
Boomi与BASE life science合作以加速整个生命科学行业的数字化转型
宾夕法尼亚州康肖霍肯 (美国商业资讯)– 智能集成和自动化领导者Boomi™今天宣布与BASE life science (BASE) 建立合作伙伴关系，BASE life science是Infosys公司旗下的一家托管服务提供商，专为生命科学行业优化基于云系统的使用。在Boomi与Infosys现有合作关系的基础上，BASE和Boomi将共同增强生命科学组织从传统技术向Veeva...
View ArticleClik here to view.
Tempus Announces Collaboration With JW Pharmaceutical to Apply Real-World...
CHICAGO Tempus, a leader in artificial intelligence and precision medicine, today announced a collaboration with JW Pharmaceutical, one of the most established pharmaceutical companies in Korea, to...
View ArticleClik here to view.
Delta-Fly Pharma Inc.: Phase I/II Study of DFP-10917 and Venetoclax in AML...
TOKUSHIMA, Japan Following to the previous information on September 10th. 2024, we are excited to share our latest development status. Enrollment of patients is progressing smoothly into the Phase I...
View ArticleClik here to view.
BeiGene Mourns Death of Beloved Board Member Donald Glazer
SAN MATEO, Calif. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, is saddened to share the news that Donald Glazer recently passed away. Don was a Board member and...
View ArticleClik here to view.
ADx NeuroSciences与Alamar Biosciences宣布合作，提供v解决方案，加速生物制药临床开发
比利时根特与加州弗里蒙特 (美国商业资讯)– ADx NeuroSciences是Fujirebio的全资子公司，也是神经退行性疾病生物标志物开发的领先企业，而Alamar Biosciences则在超灵敏免疫分析技术领域处于领先地位。今天，双方宣布合作，利用Alamar的NULISA™（核酸链接免疫分析法）免疫分析平台和ARGO™...
View ArticleClik here to view.
LabGenomics USA Completes Acquisition of IMD CLIA Labs
ROCKVILLE, Md. LabGenomics USA has successfully acquired Integrated Molecular Diagnostics (IMD) CLIA labs, bringing the total number of its CLIA-certified labs in the U.S. to four. This acquisition...
View Article
